Steven L. Wagner

11.6k total citations · 3 hit papers
78 papers, 8.4k citations indexed

About

Steven L. Wagner is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Steven L. Wagner has authored 78 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Physiology, 33 papers in Molecular Biology and 18 papers in Pharmacology. Recurrent topics in Steven L. Wagner's work include Alzheimer's disease research and treatments (55 papers), Cholinesterase and Neurodegenerative Diseases (18 papers) and Protease and Inhibitor Mechanisms (11 papers). Steven L. Wagner is often cited by papers focused on Alzheimer's disease research and treatments (55 papers), Cholinesterase and Neurodegenerative Diseases (18 papers) and Protease and Inhibitor Mechanisms (11 papers). Steven L. Wagner collaborates with scholars based in United States, Netherlands and Germany. Steven L. Wagner's co-authors include Rudolph E. Tanzi, Dennis D. Cunningham, Robert D. Moir, Gönül Veliçelebi, Shenyuan Zhang, Kenneth A. Stauderman, Maria Lioudyno, Jack Roos, Olga Safrina and Kari L. Ohlsen and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Steven L. Wagner

77 papers receiving 8.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

STIM1, an essential and conserved component of store-operated Ca2 + channel function

2005 1.5k citations Jack Roos, Paul J. DiGregorio et al. The Journal of Cell Biology profile →
Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase

2003 1.3k citations Joanna L. Jankowsky, Jeffrey C. Anderson et al. Human Molecular Genetics profile →
A three-dimensional human neural cell culture model of Alzheimer’s disease

2014 879 citations Se Hoon Choi, Can Zhang et al. profile →

Peers

Countries citing papers authored by Steven L. Wagner

Since Specialization

Citations

This map shows the geographic impact of Steven L. Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven L. Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven L. Wagner more than expected).

Fields of papers citing papers by Steven L. Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven L. Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven L. Wagner. The network helps show where Steven L. Wagner may publish in the future.

Co-authorship network of co-authors of Steven L. Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Steven L. Wagner. A scholar is included among the top collaborators of Steven L. Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven L. Wagner. Steven L. Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PS1/gamma-secretase acts as rogue chaperone of glutamate transporter EAAT2/GLT-1 in Alzheimer’s disease 2024 ·Acta Neuropathologica Communications ·(unknown), (unknown), (unknown), Priyanka Sinha, (unknown), Masato Maesako, (unknown), Can Zhang, Steven L. Wagner, Rudolph E. Tanzi, Oksana Berezovska	1
2	Endotype reversal as a novel strategy for screening drugs targeting familial Alzheimer's disease 2022 ·Alzheimer s & Dementia ·Andrew B. Caldwell, (unknown), Can Zhang, Gary P. Schroth, Douglas Galasko, Kevin D. Rynearson, Rudolph E. Tanzi, Shauna H. Yuan, Steven L. Wagner, Shankar Subramaniam	12
3	Molecular imaging of Alzheimer’s disease–related gamma-secretase in mice and nonhuman primates 2020 ·The Journal of Experimental Medicine ·Yulong Xu, Changning Wang, Hsiao‐Ying Wey, Yingxia Liang, (unknown), Se Hoon Choi, Chongzhao Ran, Kevin D. Rynearson, (unknown), (unknown), (unknown), (unknown), Steven L. Wagner, Rudolph E. Tanzi, Can Zhang	26
4	APP-Mediated Signaling Prevents Memory Decline in Alzheimer’s Disease Mouse Model 2019 ·Cell Reports ·Carole Deyts, Mary E. Clutter, (unknown), Paramita Chakrabarty, Thomas B. Ladd, (unknown), Awilda M. Rosario, Pedro E. Cruz, Kulandaivelu S. Vetrivel, Steven L. Wagner, Gopal Thinakaran, Todd E. Golde, Angèle Parent	19
5	Mechanisms Defining the Neuronal State Space 2018 ·Biophysical Journal ·Shankar Subramaniam, Andrew B. Caldwell, Vipul Bhargava, (unknown), Qing Lü, Shauna H. Yuan, Douglas Galasko, Inder M. Verma, Steven L. Wagner	2
6	Visualizing APP and BACE-1 approximation in neurons yields insight into the amyloidogenic pathway 2015 ·Nature Neuroscience ·Utpal Das, Lina Wang, Archan Ganguly, (unknown), Steven L. Wagner, Edward H. Koo, Subhojit Roy	146
7	A Synthetic Antibody Fragment Targeting Nicastrin Affects Assembly and Trafficking of γ-Secretase 2014 ·Journal of Biological Chemistry ·Xulun Zhang, Robert J. Hoey, Akiko Koide, Georgia Dolios, Marcin Paduch, Phuong Nguyen, Xianzhong Wu, Yue‐Ming Li, Steven L. Wagner, Rong Wang, Shohei Koide, Sangram S. Sisodia	4
8	NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease 2009 ·Journal of Clinical Investigation ·Nicholas H. Varvel, Kiran Bhaskar, Maria Z. Kounnas, Steven L. Wagner, Yan Yang, Bruce T. Lamb, Karl Herrup	101
9	Ubiquilin 1 Modulates Amyloid Precursor Protein Trafficking and Aβ Secretion 2006 ·Journal of Biological Chemistry ·Mikko Hiltunen, Alice Lu, Anne V. Thomas, Donna Romano, Minji Kim, P. Jones, Zhongcong Xie, Maria Z. Kounnas, Steven L. Wagner, Oksana Berezovska, Bradley T. Hyman, Giuseppina Tesco, Lars Bertram, Rudolph E. Tanzi	84
10	STIM1, an essential and conserved component of store-operated Ca2 + channel function breakdown → 2005 ·The Journal of Cell Biology ·Jack Roos, Paul J. DiGregorio, Andriy V. Yeromin, Kari L. Ohlsen, Maria Lioudyno, Shenyuan Zhang, Olga Safrina, J. Ashot Kozak, Steven L. Wagner, Michael D. Cahalan, Gönül Veliçelebi, Kenneth A. Stauderman	1506
11	How our hands help us learn 2005 ·Trends in Cognitive Sciences ·Susan Goldin‐Meadow, Steven L. Wagner	166
12	Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase breakdown → 2003 ·Human Molecular Genetics ·Joanna L. Jankowsky, (unknown), Jeffrey C. Anderson, Guilian Xu, Victoria Gonzales, Nancy A. Jenkins, Neal G. Copeland, Michael K. Lee, Linda H. Younkin, Steven L. Wagner, Steven G. Younkin, David Borchelt	1252
13	Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice 1999 ·Nature Neuroscience ·(unknown), (unknown), Laura Shapiro Kulnane, (unknown), (unknown), Steven L. Wagner, Sangram S. Sisodia, (unknown)	84
14	Enhanced Plasmin Inhibition by a Reactive Center Lysine Mutant of the Kunitz-type Protease Inhibitor Domain of the Amyloid β-Protein Precursor 1995 ·Journal of Biological Chemistry ·William E. Van Nostrand, Alvin H. Schmaier, Robert S. Siegel, Steven L. Wagner, William C. Raschke	18
15	Expression, purification, and characterization of the Kunitz-type proteinase inhibitor domain of the amyloid β-protein precursor-like protein-2 1994 ·Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·William E. Van Nostrand, Alvin H. Schmaier, (unknown), Robert S. Siegel, William C. Raschke, Sangram S. Sisodia, Steven L. Wagner	34
16	Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa. 1993 ·Journal of Clinical Investigation ·Alvin H. Schmaier, Lina Dahl, Annemieke J.M. Rozemüller, R. A. C. Roos, Steven L. Wagner, Raymond T. Chung, William E. Van Nostrand	91
17	Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis–dutch type share a decrease in cerebrospinal fluid levels of amyloid β‐protein precursor 1992 ·Annals of Neurology ·(unknown), Steven L. Wagner, Joost Haan, Egbert Bakker, Raymund A.C. Roos	26
18	Regulation of Protease Nexin-1 Activity by Heparin and Heparan Sulfate 1992 ·Advances in experimental medicine and biology ·Dennis D. Cunningham, Steven L. Wagner, David H. Farrell	12
19	Inhibitors of Urokinase and Thrombin in Cultured Neural Cells 1991 ·Journal of Neurochemistry ·Steven L. Wagner, Alice Lau, Ann Nguyen, Jun Mimuro, David J. Loskutoff, Paul J. Isackson, Dennis D. Cunningham	21
20	Purification of a form of protease nexin-1 that binds heparin with a low affinity 1988 ·Biochemistry ·William E. Van Nostrand, Steven L. Wagner, Dennis D. Cunningham	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact